Approvals/CIMA-AEMPS/RIVAROXABAN SWANPOND INVESTMENTS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

RIVAROXABAN SWANPOND INVESTMENTS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Swan Pond Investments Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ff5c5cfa8d352b13
Drug Cima Aemps Name: RIVAROXABAN SWANPOND INVESTMENTS 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 86207
Holder Company Name: Swan Pond Investments Limited
Marketing Company Name: Swan Pond Investments Limited
Authorization Date: 2021-09-17
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 20 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Swan Pond Investments Limited

RIVAROXABAN

20 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 17, 2021

Approval ID

ff5c5cfa8d352b13

Type

Standard